Manulife (Manufacturers Life Insurance)’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $102K | Buy |
27,262
+2,097
| +8% | +$7.82K | ﹤0.01% | 2753 |
|
2025
Q1 | $69.5K | Buy |
25,165
+787
| +3% | +$2.17K | ﹤0.01% | 2778 |
|
2024
Q4 | $135K | Sell |
24,378
-41,722
| -63% | -$231K | ﹤0.01% | 2758 |
|
2024
Q3 | $551K | Buy |
66,100
+43,455
| +192% | +$362K | ﹤0.01% | 2238 |
|
2024
Q2 | $154K | Buy |
22,645
+5,049
| +29% | +$34.4K | ﹤0.01% | 2699 |
|
2024
Q1 | $115K | Sell |
17,596
-2,173
| -11% | -$14.3K | ﹤0.01% | 2747 |
|
2023
Q4 | $128K | Buy |
19,769
+2,789
| +16% | +$18.1K | ﹤0.01% | 2750 |
|
2023
Q3 | $85.4K | Buy |
16,980
+144
| +0.9% | +$724 | ﹤0.01% | 2855 |
|
2023
Q2 | $147K | Buy |
+16,836
| New | +$147K | ﹤0.01% | 2723 |
|